Venus Remedies Limited has informed the Exchange about Shareholders meeting
VENUSREM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Venus Remedies Limited held its 36th Annual General Meeting on 22nd August 2025 at 11:30 AM via video conferencing, with 50 members in attendance. Chairman and Managing Director Mr. Pawan Chaudhary presented the company's performance for FY 2024-25 and outlined future outlook. A total of 10 resolutions were put to vote, including adoption of audited standalone and consolidated financial statements for the year ended 31st March 2025, ratification of cost auditors' remuneration of Rs. 1,10,000 per annum for FY 2025-26, and re-appointments of key directors for five-year terms. E-voting ran from 19th to 21st August 2025, and combined voting results are to be declared within 48 hours of meeting conclusion.
This is a routine procedural filing with no major surprises; the re-appointments signal leadership continuity at Venus Remedies. Investors should watch for the formal voting results to be filed separately, as this current disclosure does not include the actual vote tallies.